Viewing Study NCT06190093


Ignite Creation Date: 2025-12-25 @ 1:12 AM
Ignite Modification Date: 2025-12-25 @ 1:12 AM
Study NCT ID: NCT06190093
Status: COMPLETED
Last Update Posted: 2025-02-25
First Post: 2023-12-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects with Neovascular Age-related Macular Degeneration (AMD)
Sponsor: Outlook Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module